Imvax
Imvax is a clinical-stage biotechnology company focused on the development of patient-specific vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers with unmet medical needs.
CEO
CFO
Company Operating Status
Active
Country
Crunchbase URL
Date Incorporated
2015
Email Address
Founded Date
2015
Full Address
601 Walnut Street, Suite 440W, Philadelphia, PA 19106
Latest Funding Round Date
July 2020
Latest Funding Round Amount (USD)
112,370,500
Latest Funding Type
LinkedIn URL
Location
Phone Number
Pitchbook URL
Total Funding Amount (USD)
192,370,500
Twitter URL
Official Website
Find more companies like Imvax
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.